Vista Pharmaceuticals P/B Ratio
Vista Pharmaceuticals (VISTAPH) P/B ratio is 1.01 (Moderate), book value per share ₹37.50 vs Healthcare average P/B of -0.33 — Moderate - Reasonably valued relative to book value. Compare with VISTAPH stock valuation models to assess whether the stock is under or overvalued.
Current Valuation Metrics
Book Value Breakdown (2025)
Valuation Signal
Sector Context
VISTAPH P/B Ratio — Valuation Insights & Book Value Analysis
Vista Pharmaceuticals price-to-book ratio interpretation, valuation status and historical context — current P/B 1.01 (Moderate). View VISTAPH price range for the annual high/low range and current price position.
- Current PB is 304.0% above historical average
- Trading at premium to sector average PB of -0.33
Vista Pharmaceuticals P/B Ratio Historical Trend
VISTAPH annual price-to-book ratio — 5 years, book value per share and year-end price. P/B below 1.0 indicates the stock trades below net asset value. For live price, earnings yield and the full fundamental profile, see Vista Pharmaceuticals share price chart.
VISTAPH Historical P/B Ratio — Book Value Per Share & Year-End Price
Vista Pharmaceuticals annual P/B ratio, book value per share (₹), year-end price and total equity in ₹ Crores.
| Year | P/B Ratio | Book Value/Share (₹) | Year-end Price (₹) | Total Equity (₹ Cr) | Valuation |
|---|---|---|---|---|---|
| 2025 | 0.22 | ₹37.5 | ₹8.14 | ₹45 | Low |
| 2024 | 0.26 | ₹45.56 | ₹11.78 | ₹41 | Low |
| 2023 | 0.32 | ₹46.25 | ₹14.67 | ₹37 | Low |
| 2022 | 0.23 | ₹51.43 | ₹11.78 | ₹36 | Low |
| 2021 | 0.22 | ₹47.14 | ₹10.33 | ₹33 | Low |
VISTAPH vs Healthcare Peers — P/B Ratio Comparison
Vista Pharmaceuticals P/B 1.01 vs Healthcare average -0.33, median 0.63 — range -17.92–1.01.
| Company | Symbol | P/B Ratio | Market Cap (₹ Cr) | Valuation |
|---|---|---|---|---|
| Rekvina Laboratories | VINRKLB | -17.92 | ₹22 | Low |
| Span Divergent | SDL | -6.32 | ₹19 | Low |
| Oxygenta Pharmaceutical | OXYGENTAPH | -5.54 | ₹203 | Low |
| Satiate Agri | SATAGRI | -3.39 | ₹8 | Low |
| Adline Chem Lab | ADLINE | -3.03 | ₹5 | Low |
| Parmax Pharma | PARMAX | -2.48 | ₹14 | Low |
| Bharat Immunologicals | BIBCL | -2.32 | ₹76 | Low |
| Krebs Biochemicals & Ind… | KREBSBIO | -0.71 | ₹127 | Low |
| Cresanto Global | CRESANTO | -0.7 | ₹2 | Low |
| Vivimed Labs | VIVIMEDLAB | -0.63 | ₹53 | Low |